{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:22:29Z","timestamp":1671798149796},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.0599","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T06:47:35Z","timestamp":1383288455000},"page":"2409-2415","source":"Crossref","is-referenced-by-count":2,"title":["Lack of Goal Attainment Regarding the Low-density Lipoprotein Cholesterol Level in the Management of Type 2 Diabetes Mellitus"],"prefix":"10.2169","volume":"52","author":[{"given":"Masaya","family":"Hosokawa","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"},{"name":"Faculty of Human Sciences, Tezukayamagakuin University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Hamasaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Harashima","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihito","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nakahigashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"},{"name":"Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389, 1994."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009, 1996.","DOI":"10.1056\/NEJM199610033351401"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357, 1998.","DOI":"10.1056\/NEJM199811053391902"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22, 2002.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307, 1995.","DOI":"10.1056\/NEJM199511163332001"},{"key":"6","unstructured":"6. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS: Air Force\/Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615-1622, 1998."},{"key":"7","unstructured":"7. Shepherd J, Blauw GJ, Murphy MB, PROSPER study group, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360: 1623-1630, 2002."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383-393, 2003.","DOI":"10.1056\/NEJMoa021778"},{"key":"9","unstructured":"9. Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. 2008: 29."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cannon CP, Braunwald E, McCabe CH, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495-1504, 2004.","DOI":"10.1056\/NEJMoa040583"},{"key":"11","unstructured":"11. Nissen SE, Tuzcu EM, Schoenhagen P, REVERSAL Investigators, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291: 1071-1080, 2004."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 28: 595-599, 2005.","DOI":"10.2337\/diacare.28.3.595"},{"key":"13","unstructured":"13. Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Diseases. 2002: 9."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. The committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 1: 212-228, 2010.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"15","unstructured":"15. Tsurumaru M, Yamaguchi Y, Yamakawa K, et al. The control of cholesterol, HbA1c, blood pressure in diabetic patients accompanied with hypercholesterolemia. Journal of the Japan Diabetes Society 45: 773-778, 2002 (in Japanese)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matthan NR, Pencina M, LaRocque JM, et al. Alterations in cholesterol absorption\/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res 50: 1927-1935, 2009.","DOI":"10.1194\/jlr.P900039-JLR200"},{"key":"17","unstructured":"17. Uemura Y, Watarai M, Ishii H, et al. Atorvastatin 10 mg plus ezetimibe 10 mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease. J Cardiol 59: 50-56, 2012."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Leiter LA, Betteridge DJ, Chacra AR, et al. AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus. Achieving Best Practice 6: 31-40, 2006.","DOI":"10.1177\/14746514060060010401"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Grant RW, Pirraglia PA, Meigs JB, Singer DE. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 164: 1134-1139, 2004.","DOI":"10.1001\/archinte.164.10.1134"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/21\/52_52.0599\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:47:12Z","timestamp":1621446432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/21\/52_52.0599\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.0599","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}